Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea

Summary

The purpose of this study is to evaluate the safety and clinical efficacy of VM202RY injected via transendocardial route using C-Cathez® catheter (Celyad, S.A., Belgium) in subjects with AMI. * Stage 1: Evaluation of safety and tolerability of VM202RY injection * Stage 2: Evaluation of safety and efficacy of VM202RY injection

Timeline

Start

2018-01-25

Primary completion

2019-08-20

Completion

2019-08-20

Outcome

Outcome not reported

Stopped: “Company decided not to move forward with this study.”

Drugs

Indications